Terumo Corporation
No trades
No trades
Compare with Terumo Corporation
111.5 JPY
135.91 B JPY
1.13 T JPY
1.30 B
Last report date
Aug 7, 2026
Report period
Q1 2026
EPS
47.74 JPY
Revenue
311.81 B JPY
Earnings call summary
Preparations for the Lacanbi auto injector launch are progressing, with cardiovascular growth led by volume and sustainable price increases. Significant compensation was received for a prior project cancellation, and China neuro sales rose due to VBP volume commitments.
Details
Sector
Industry
CEO
Hikaru Samejima
Website
Headquarters
Tokyo
Founded
1921
IPO date
Jun 21, 1982
ISIN
JP3546800008
FIGI
BBG000BK09M8
Identifiers
ISIN JP3546800008
Terumo Corp. engages in the manufacture and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateApr 28, 2031
Coupon4.49% (Fixed)
See all 4543 bonds
Frequently asked questions
The current price of 4543 is 2,575.5 JPY — it has increased by 8.53% in the past 24 hours. Watch Terumo Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange Terumo Corporation stocks are traded under the ticker 4543.
4543 stock has risen by 11.98% compared to the previous week, the month change is a 14.04% rise, over the last year Terumo Corporation has showed a −6.77% decrease.
We've gathered analysts' opinions on Terumo Corporation future price: according to them, 4543 price has a max estimate of 3,800.00 JPY and a min estimate of 2,450.00 JPY. Watch 4543 chart and read a more detailed Terumo Corporation stock forecast: see what analysts think of Terumo Corporation and suggest that you do with its stocks.
4543 reached its all-time high on Nov 12, 2024 with the price of 3,182.0 JPY, and its all-time low was 168.0 JPY and was reached on Feb 4, 2002. View more price dynamics on 4543 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4543 stock is 8.41% volatile and has beta coefficient of 0.31. Track Terumo Corporation stock price on the chart and check out the list of the most volatile stocks — is Terumo Corporation there?
Today Terumo Corporation has the market capitalization of 3.50 T, it has increased by 4.09% over the last week.
Yes, you can track Terumo Corporation financials in yearly and quarterly reports right on TradingView.
Terumo Corporation is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
4543 earnings for the last quarter are 47.74 JPY per share, whereas the estimation was 25.89 JPY resulting in a 84.43% surprise. The estimated earnings for the next quarter are 26.75 JPY per share. See more details about Terumo Corporation earnings.
Terumo Corporation revenue for the last quarter amounts to 311.81 B JPY, despite the estimated figure of 295.46 B JPY. In the next quarter, revenue is expected to reach 307.97 B JPY.
4543 net income for the last quarter is 70.43 B JPY, while the quarter before that showed 26.37 B JPY of net income which accounts for 0.00% change. Track more Terumo Corporation financial stats to get the full picture.
Terumo Corporation dividend yield was 1.42% in 2025, and payout ratio reached 32.56%. The year before the numbers were 0.93% and 32.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 11, 2026, the company has 31.18 K employees. See our rating of the largest employees — is Terumo Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Terumo Corporation EBITDA is 301.48 B JPY, and current EBITDA margin is 24.75%. See more stats in Terumo Corporation financial statements.
Like other stocks, 4543 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Terumo Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Terumo Corporation technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Terumo Corporation stock shows the strong buy signal. See more of Terumo Corporation technicals for a more comprehensive analysis.